IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice

Biology Direct

Volumn 7, Issue , 2012, Pages

  Greenspan, Neil S ^a   Lu, Myro A ^a   Shipley, Jacob W ^a   Ding, Xuedong ^a   Li, Qing ^a   Sultana, Dilara ^a   Kollaros, Maria ^b   Schreiber, John R ^a,d   Fu, Pingfu ^a   Putterman, Chaim ^b   Emancipator, Steven N ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

ACTININ; AUTOANTIBODY; CREATININE; DNA; IMMUNOGLOBULIN G;

AGE; ALLELE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CYTOLOGY; DISEASE COURSE; FEMALE; GENETICS; GENOTYPE; GLOMERULONEPHRITIS; IMMUNE DEFICIENCY; IMMUNOLOGY; INBREEDING; KIDNEY; LONGEVITY; MALE; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; URINE;

ACTININ; AGE FACTORS; ALLELES; ANIMALS; AUTOANTIBODIES; CREATININE; DISEASE PROGRESSION; DNA; FEMALE; GENOTYPE; GLOMERULONEPHRITIS; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; INBREEDING; KIDNEY; LONGEVITY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED MRL LPR; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL ANALYSIS;

EID: 84855800449     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-7-3     Document Type: Article

References (52)

1. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978, 148(5):1198-215. 10.1084/jem.148.5.1198, 2185049, 309911.
2. Dixon FJ, Andrews BS, Eisenberg RA, McConahey PJ, Theofilopoulos AN, Wilson CB. Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum 1978, 21(5 Suppl):S64-7.
3. Kelley VE, Winkelstein A, Izui S, Dixon FJ. Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL/1 mice. Clin Immunol Immunopathol 1981, 21(2):190-203. 10.1016/0090-1229(81)90208-7, 7028332.
4. Hahn BH. Antibodies to DNA. N Engl J Med 1998, 338(19):1359-68. 10.1056/NEJM199805073381906, 9571257.
5. Madaio MP, Shlomchik MJ. Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis. B cells have multiple roles; all autoantibodies are not equal. J Am Soc Nephrol 1996, 7(3):387-96.
6. Peng SL, Szabo SJ, Glimcher LH. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci USA 2002, 99(8):5545-50. 10.1073/pnas.082114899, 122806, 11960012.
7. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 1991, 147:515-9.
8. Santiago ML, Fossati L, Jacquet C, Muller W, Izui S, Reininger L. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997, 185:65-70. 10.1084/jem.185.1.65, 2196109, 8996242.
9. Erausquin C, Merino R, Izui S, Fernandez-Sueiro L, Saez F, Fernandez F, Rodriguez-Valverde V, Merino J. Therapeutic effect of early thymic irradiation in (NZB × NZW)F1 mice, associated with a selective decrease in the levels of IgG3 and gp70-anti-gp70 immune complexes. Cell Immunol 1995, 161:207-12. 10.1006/cimm.1995.1028, 7697731.
10. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 2000, 97(3):1184-9. 10.1073/pnas.97.3.1184, 15562, 10655505.
11. Reininger L, Berney T, Shibata T, Spertini F, Merino R, Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc Natl Acad Sci USA 1990, 87:10038-42. 10.1073/pnas.87.24.10038, 55310, 2263605.
12. Berney T, Shibata T, Izui S. Murine cryoglobulinemia: pathogenic and protective IgG3 self-associating antibodies. J Immunol 1991, 147:3331-5.
13. Lemoine R, Berney T, Shibata T, Fulpius T, Gyotoku Y, Shimada H, Sawada S, Izui S. Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int 1992, 41(1):65-72. 10.1038/ki.1992.9, 1593863.
14. Fulpius T, Spertini F, Reininger L, Izui S. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc Natl Acad Sci USA 1993, 90(6):2345-9. 10.1073/pnas.90.6.2345, 46083, 8460145.
15. Grey HM, Hirst JW, Cohn M. A new mouse immunoglobulin: IgG3. J Exp Med 1971, 133(2):289-304. 10.1084/jem.133.2.289, 2138907, 5133863.
16. Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. J Immunol 1987, 138:3785-3792.
17. Abdelmoula M, Spertini F, Shibata T, Gyotoku Y, Luzuy S, Lambert PH, Izui S. IgG3 is the major source of cryoglobulins in mice. J Immunol 1989, 143(2):526-32.
18. García-González M, Bettinger S, Ott S, Olivier P, Kadouche J, Pouletty P. Purification of murine IgG3 and IgM monoclonal antibodies by euglobulin precipitation. J Immunol Methods 1988, 111(1):17-23. 10.1016/0022-1759(88)90054-3, 3292650.
19. Spertini F, Coulie PG, Van Snick J, Davidson E, Lambert PH, Izui S. Inhibition of cryoprecipitation of murine IgG3 anti-dinitrophenyl (DNP) monoclonal antibodies by anionic DNP-amino acid conjugates. Eur J Immunol 1989, 19:273-278. 10.1002/eji.1830190209, 2495223.
20. Jiskoot W, Hoven AM, De Koning AA, Leerling MF, Reubsaet CH, Crommelin DJ, Beuvery EC. Purification and stabilisation of a poorly soluble mouse IgG3 monoclonal antibody. J Immunol Methods 1991, 138(2):181-9. 10.1016/0022-1759(91)90166-D, 1827821.
21. Greenspan NS, Monafo WJ, Davie JM. Interaction of IgG3 anti-streptococcal group A carbohydrate (GAC) antibody with streptococcal group A vaccine: enhancing and inhibiting effects of anti-GAC, anti-isotypic, and anti-idiotypic antibodies. J Immunol 1987, 138(1):285-92.
22. Greenspan NS, Dacek DA, Cooper LJ. Fc region-dependence of IgG3 anti-streptococcal group A carbohydrate antibody functional affinity. I. The effect of temperature. J Immunol 1988, 141(12):4276-82.
23. Cooper LJ, Schimenti JC, Glass DD, Greenspan NS. H chain C domains influence the strength of binding of IgG for streptococcal group A carbohydrate. J Immunol 1991, 146(8):2659-63.
24. Cooper LJ, Robertson D, Granzow R, Greenspan NS. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Mol Immunol 1994, 31(8):577-84. 10.1016/0161-5890(94)90165-1, 7515151.
25. Greenspan NS, Cooper LJ. Intermolecular cooperativity: a clue to why mice have IgG3?. Immunol Today 1992, 13(5):164-8. 10.1016/0167-5699(92)90120-V, 1642754.
26. Perlmutter RM, Hansburg D, Briles DE, Nicolotti RA, Davie JM. Subclass restriction of murine anti-carbohydrate antibodies. J Immunol 1978, 121(2):566-72.
27. McLay J, Leonard E, Petersen S, Shapiro D, Greenspan NS, Schreiber JR. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. J Immunol 2002, 168(7):3437-43.
28. Metzger H. Transmembrane signaling: the joy of aggregation. J Immunol 1992, 149(5):1477-87.
29. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985, 37:269-390.
30. Shapiro DA, Threadgill DS, Copfer MJ, Corey DA, McCool TL, McCormick LL, Magnuson TR, Greenspan NS, Schreiber JR. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines. J Immunol 1998, 161(7):3393-9.
31. Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med 2002, 195(9):1167-74. 10.1084/jem.20020165, 2193704, 11994421.
32. Kotzin BL, West SG. Systemic Lupus Erythematosus. Clinical Immunology: Principles and Practice 2001, 60.1-60.24. Mosby, London, Rich RR, Second.
33. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S. Imbalance towards Th1 predominance is associated with acceleration of lupus- like autoimmune syndrome in MRL mice. J Clin Invest 1996, 97:1597-604. 10.1172/JCI118584, 507222, 8601623.
34. Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, Cook HT, Walport MJ, Vyse TJ, Botto M. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2004, 2(8):E243. Epub 2004 Aug 17, 10.1371/journal.pbio.0020243, 509305, 15314659.
35. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987, 236(4804):944-7. 10.1126/science.3107127, 3107127.
36. Snapper CM, McIntyre TM, Mandler R, Pecanha LM, Finkelman FD, Lees A, Mond JJ. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 1992, 175(5):1367-71. 10.1084/jem.175.5.1367, 2119217, 1373759.
37. Agodoa LY, Gauthier VJ, Mannik M. Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med 1983, 158(4):1259-71. 10.1084/jem.158.4.1259, 2187360, 6225823.
38. Gauthier VJ, Mannik M. Only the initial binding of cationic immune complexes to glomerular anionic sites is mediated by charge-charge interactions. J Immunol 1986, 136(9):3266-71.
39. Mannik M, Gauthier VJ, Stapleton SA, Agodoa LY. Immune complexes with cationic antibodies deposit in glomeruli more effectively than cationic antibodies alone. J Immunol 1987, 138(12):4209-17.
40. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001, 15:397-408. 10.1016/S1074-7613(01)00201-1, 11567630.
41. Tarasenko T, Kole HK, Bolland S. A lupus-suppressor BALB/c locus restricts IgG2 autoantibodies without altering intrinsic B cell-tolerance mechanisms. J Immunol 2008, 180(6):3807-14.
42. Haraldsson MK, Louis-Dit-Sully CA, Lawson BR, Sternik G, Santiago-Raber ML, Gascoigne NR, Theofilopoulos AN, Kono DH. The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity 2008, 28(1):40-51. 10.1016/j.immuni.2007.11.023, 2274909, 18199416.
43. Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect Immun 2005, 73(3):1304-12. 10.1128/IAI.73.3.1304-1312.2005, 1064945, 15731027.
44. Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998, 188:29-38. 10.1084/jem.188.1.29, 2525538, 9653081.
45. Deocharan B, Qing X, Lichauco J, Putterman C. alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 2002, 168:3072-8.
46. Mason LJ, Ravirajan CT, Rahman A, Putterman C, Isenberg DA. Is α-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?. Arthritis Rheum 2004, 50:866-70. 10.1002/art.20103, 15022329.
47. Ebling F, Hahn BH. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus: comparison of antibodies in serum and renal eluates. Arthritis Rheum 1980, 23:392-403. 10.1002/art.1780230402, 7370058.
48. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 1976, 10.1016/0003-2697(76)90527-3, 942051.
49. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 1973, 43:305. 10.1016/0009-8981(73)90466-X, 4690902.
50. Chintalacharuvu SR, Nagy NU, Sigmund N, Nedrud JG, Amm ME, Emancipator SN. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 2001, 126(2):326-33. 10.1046/j.1365-2249.2001.01678.x, 1906199, 11703378.
51. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-81.
52. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc B 1972, 34:187-220.